Zevor-cel

CT053 · CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zevor-cel, covering 2023-12-19 to 2023-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2) [Phase 1, Phase 2]

See pricing